A 10-Long Non-Coding RNA-Based Expression Signature as a Potential Biomarker for Prognosis of Acute Myeloid Leukemia.
CONCLUSIONS We developed a 10-lncRNA expression signature to predict the clinical outcome of AML. This approach demonstrates remarkable prognostic and therapeutic potential for AML.
PMID: 31278736 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Biomedical Science | Cancer | Cancer & Oncology | Databases & Libraries | Leukemia | Research | Science | Study